Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Arterial Spin Labeling Magnetic Resonance Imaging for Differentiating Acute Ischemic Stroke from Epileptic Disorders.

Kanazawa Y, Arakawa S, Shimogawa T, Hagiwara N, Haga S, Morioka T, Ooboshi H, Ago T, Kitazono T.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1684-1690. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.020. Epub 2019 Mar 14.

PMID:
30878365
2.

C-reactive protein and incident hypertension in a worksite population of Japanese men.

Kansui Y, Matsumura K, Morinaga Y, Inoue M, Kiyohara K, Ohta Y, Goto K, Ohtsubo T, Ooboshi H, Kitazono T.

J Clin Hypertens (Greenwich). 2019 Apr;21(4):524-532. doi: 10.1111/jch.13510. Epub 2019 Mar 4.

3.

Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study.

Tanaka S, Ninomiya T, Hiyamuta H, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Nakano T, Tsuruya K, Kitazono T.

Sci Rep. 2019 Jan 31;9(1):1043. doi: 10.1038/s41598-018-37961-1.

4.

Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.

Tsuyama J, Nakamura A, Ooboshi H, Yoshimura A, Shichita T.

Semin Immunopathol. 2018 Nov;40(6):523-538. doi: 10.1007/s00281-018-0707-8. Epub 2018 Sep 11. Review.

PMID:
30206661
5.

Impact of obstructive sleep apnea on long-term blood pressure variability in Japanese men: a cross-sectional study of a work-site population.

Kansui Y, Matsumura K, Morinaga Y, Inoue M, Sakata S, Oishi E, Goto K, Ohtsubo T, Ooboshi H, Kitazono T.

Hypertens Res. 2018 Nov;41(11):957-964. doi: 10.1038/s41440-018-0096-3. Epub 2018 Sep 11.

PMID:
30206322
6.

Impact of serum uric acid on incident hypertension in a worksite population of Japanese men.

Kansui Y, Matsumura K, Morinaga Y, Inoue M, Kiyohara K, Ohta Y, Goto K, Ohtsubo T, Ooboshi H, Kitazono T.

J Hypertens. 2018 Jul;36(7):1499-1505. doi: 10.1097/HJH.0000000000001743.

PMID:
29746372
7.

Impact of blood urea nitrogen to creatinine ratio on mortality and morbidity in hemodialysis patients: The Q-Cohort Study.

Tanaka S, Ninomiya T, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Kitazono T, Tsuruya K.

Sci Rep. 2017 Nov 2;7(1):14901. doi: 10.1038/s41598-017-14205-2.

8.

Secular trends in the incidence of end-stage renal disease and its risk factors in Japanese patients with immunoglobulin A nephropathy.

Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Tokumoto M, Hirakata H, Ooboshi H, Kitazono T, Tsuruya K.

Nephrol Dial Transplant. 2018 Jun 1;33(6):963-971. doi: 10.1093/ndt/gfx223.

PMID:
28992313
9.

Hypercalcaemia-induced acute kidney injury in an older patient with osteoporosis treated with alfacalcidol for denosumab-induced hypocalcaemia.

Yamada S, Matsuo M, Tokumoto M, Ooboshi H.

Nephrology (Carlton). 2017 Jul;22(7):572-573. doi: 10.1111/nep.12843. No abstract available.

PMID:
28621008
10.

Extrapulmonary tuberculosis presented as fever of unknown origin in two patients with endstage kidney disease not on dialysis: usefulness of 18-FDG-PET/CT in the diagnostic localization of fever of unknown origin.

Yamada S, Ueki K, Kawai Y, Sako T, Shimomura Y, Tsuchimoto A, Tanaka S, Matsui R, Maeda H, Tokumoto M, Ooboshi H, Kitazono T, Tsuruya K.

CEN Case Rep. 2016 May;5(1):11-17. doi: 10.1007/s13730-015-0181-2. Epub 2015 Apr 21.

11.

MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1.

Shichita T, Ito M, Morita R, Komai K, Noguchi Y, Ooboshi H, Koshida R, Takahashi S, Kodama T, Yoshimura A.

Nat Med. 2017 Jun;23(6):723-732. doi: 10.1038/nm.4312. Epub 2017 Apr 10.

PMID:
28394332
12.

Total Phosphate Elimination is Negatively Associated With Increased Serum Fibroblast Growth Factor 23 Levels in Patients who Undergo Peritoneal Dialysis.

Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Tatsumoto N, Ooboshi H, Kitazono T.

Ther Apher Dial. 2017 Feb;21(1):71-78. doi: 10.1111/1744-9987.12478. Epub 2017 Jan 12.

PMID:
28078749
13.

[DAMPs (damage-associated molecular patterns) and inflammation].

Ooboshi H, Shichita T.

Nihon Rinsho. 2016 Apr;74(4):573-8. Review. Japanese.

PMID:
27333742
14.

Comparison of oral versus intravenous vitamin D receptor activator in reducing infection-related mortality in hemodialysis patients: the Q-Cohort Study.

Tanaka S, Ninomiya T, Taniguchi M, Fujisaki K, Tokumoto M, Hirakata H, Ooboshi H, Kitazono T, Tsuruya K.

Nephrol Dial Transplant. 2016 Jul;31(7):1152-60. doi: 10.1093/ndt/gfw205. Epub 2016 May 27.

PMID:
27235424
15.

Factors Associated with the Serum Myostatin Level in Patients Undergoing Peritoneal Dialysis: Potential Effects of Skeletal Muscle Mass and Vitamin D Receptor Activator Use.

Yamada S, Tsuruya K, Yoshida H, Tokumoto M, Ueki K, Ooboshi H, Kitazono T.

Calcif Tissue Int. 2016 Jul;99(1):13-22. doi: 10.1007/s00223-016-0118-6. Epub 2016 Feb 19.

PMID:
26895008
16.

Pseudohyperchloraemia caused by long-term use of analgesic containing bromovaleryl urea.

Yamada S, Tokumoto M, Ooboshi H.

Nephrology (Carlton). 2016 Feb;21(2):161-2. doi: 10.1111/nep.12566. No abstract available.

PMID:
26799464
17.

Very low protein diet enhances inflammation, malnutrition, and vascular calcification in uremic rats.

Yamada S, Tokumoto M, Tatsumoto N, Tsuruya K, Kitazono T, Ooboshi H.

Life Sci. 2016 Feb 1;146:117-23. doi: 10.1016/j.lfs.2015.12.050. Epub 2016 Jan 4.

PMID:
26764234
18.

Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic stroke.

Nakamura K, Arimura K, Nishimura A, Tachibana M, Yoshikawa Y, Makihara N, Wakisaka Y, Kuroda J, Kamouchi M, Ooboshi H, Kitazono T, Ago T.

Brain Res. 2016 Jan 1;1630:98-108. doi: 10.1016/j.brainres.2015.11.003. Epub 2015 Nov 10.

PMID:
26569132
19.

Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia.

Yamada S, Tokumoto M, Tsuruya K, Tatsumoto N, Noguchi H, Kitazono T, Ooboshi H.

Am J Physiol Renal Physiol. 2015 Oct 15;309(8):F744-54. doi: 10.1152/ajprenal.00017.2015. Epub 2015 Jul 15.

20.

Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.

Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Ooboshi H, Kitazono T.

Nephrology (Carlton). 2015 Sep;20(9):639-45. doi: 10.1111/nep.12509.

PMID:
25974190
21.

Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.

Yamada S, Tokumoto M, Taniguchi M, Toyonaga J, Suehiro T, Eriguchi R, Fujimi S, Ooboshi H, Kitazono T, Tsuruya K.

Ther Apher Dial. 2015 Aug;19(4):367-77. doi: 10.1111/1744-9987.12292. Epub 2015 Apr 7. Erratum in: Ther Apher Dial. 2016 Jun;20(3):329.

PMID:
25851690
22.

A CADASIL-Like Case with a Novel Noncysteine Mutation of the NOTCH3 Gene and Granular Deposits in the Renal Arterioles.

Nakamura K, Ago T, Tsuchimoto A, Noda N, Nakamura A, Ninomiya T, Uchiumi T, Tsuruya K, Kamouchi M, Ooboshi H, Kitazono T.

Case Rep Neurol Med. 2015;2015:431461. doi: 10.1155/2015/431461. Epub 2015 Mar 9.

23.

Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.

Yamada S, Tatsumoto N, Tokumoto M, Noguchi H, Ooboshi H, Kitazono T, Tsuruya K.

Calcif Tissue Int. 2015 Apr;96(4):347-58. doi: 10.1007/s00223-014-9929-5. Epub 2014 Dec 16.

PMID:
25511229
24.

Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis.

Yamada S, Tsuchimoto A, Kaizu Y, Taniguchi M, Masutani K, Tsukamoto H, Ooboshi H, Tsuruya K, Kitazono T.

CEN Case Rep. 2014 Nov;3(2):237-243. doi: 10.1007/s13730-014-0127-0. Epub 2014 Jul 29.

25.

Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.

Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Masutani K, Ooboshi H, Kitazono T.

Ther Apher Dial. 2015 Feb;19(1):73-80. doi: 10.1111/1744-9987.12221. Epub 2014 Sep 4.

PMID:
25195562
26.

Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.

Yamada S, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K, Kitazono T.

Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1418-28. doi: 10.1152/ajprenal.00633.2013. Epub 2014 May 7.

27.

Plasma S100A12 is associated with functional outcome after ischemic stroke: Research for Biomarkers in Ischemic Stroke.

Wakisaka Y, Ago T, Kamouchi M, Kuroda J, Matsuo R, Hata J, Gotoh S, Isomura T, Awano H, Suzuki K, Fukuda K, Okada Y, Kiyohara Y, Ooboshi H, Kitazono T; REBIOS Investigators.

J Neurol Sci. 2014 May 15;340(1-2):75-9. doi: 10.1016/j.jns.2014.02.031. Epub 2014 Mar 4.

PMID:
24629476
28.

[IT network establishment for neuropatients].

Abe K, Uchiyama S, Matsubara E, Muramatsu S, Atsuta N, Kitagawa K, Iguchi Y, Ooboshi H, Kaji R, Terao Y.

Rinsho Shinkeigaku. 2013;53(11):1155-8. Japanese.

PMID:
24291913
29.

Slowly progressive and painless thoracic aortic dissection presenting with a persistent Fever in an elderly patient: the usefulness of combined measurement of biochemical parameters.

Yamada S, Tokumoto M, Ohkuma T, Kansui Y, Wakisaka Y, Uchizono Y, Tsuruya K, Kitazono T, Ooboshi H.

Case Rep Med. 2013;2013:498129. doi: 10.1155/2013/498129. Epub 2013 Jun 17.

30.

Severe metabolic alkalosis, hypokalemia, and respiratory acidosis induced by the Chinese herbal medicine yokukansan in an elderly patient with muscle weakness and drowsiness.

Yamada S, Tokumoto M, Kansui Y, Wakisaka Y, Uchizono Y, Tsuruya K, Ooboshi H.

CEN Case Rep. 2013 May;2(1):23-27. doi: 10.1007/s13730-012-0032-3. Epub 2012 Sep 12.

31.

Neuroprotection after cerebral ischemia.

Namura S, Ooboshi H, Liu J, Yenari MA.

Ann N Y Acad Sci. 2013 Mar;1278:25-32. doi: 10.1111/nyas.12087.

32.

Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke.

Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Ooboshi H.

J Neurochem. 2012 Nov;123 Suppl 2:29-38. doi: 10.1111/j.1471-4159.2012.07941.x. Review.

33.

Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain.

Shichita T, Hasegawa E, Kimura A, Morita R, Sakaguchi R, Takada I, Sekiya T, Ooboshi H, Kitazono T, Yanagawa T, Ishii T, Takahashi H, Mori S, Nishibori M, Kuroda K, Akira S, Miyake K, Yoshimura A.

Nat Med. 2012 Jun;18(6):911-7. doi: 10.1038/nm.2749.

PMID:
22610280
34.

PDGF receptor β signaling in pericytes following ischemic brain injury.

Arimura K, Ago T, Kamouchi M, Nakamura K, Ishitsuka K, Kuroda J, Sugimori H, Ooboshi H, Sasaki T, Kitazono T.

Curr Neurovasc Res. 2012 Feb;9(1):1-9.

PMID:
22272762
35.

Gene therapy as a novel pharmaceutical intervention for stroke.

Ooboshi H.

Curr Pharm Des. 2011;17(5):424-33. Review.

PMID:
21375487
36.

Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.

Sumida A, Horiba M, Ishiguro H, Takenaka H, Ueda N, Ooboshi H, Opthof T, Kadomatsu K, Kodama I.

Cardiovasc Res. 2010 Apr 1;86(1):113-21. doi: 10.1093/cvr/cvp386. Epub 2009 Dec 7.

PMID:
19969622
37.

Change in intracellular pH causes the toxic Ca2+ entry via NCX1 in neuron- and glia-derived cells.

Shono Y, Kamouchi M, Kitazono T, Kuroda J, Nakamura K, Hagiwara N, Ooboshi H, Ibayashi S, Iida M.

Cell Mol Neurobiol. 2010 Apr;30(3):453-60. doi: 10.1007/s10571-009-9470-7. Epub 2009 Oct 15.

PMID:
19830548
38.

Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury.

Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ, Iwakura Y, Yoshimura A.

Nat Med. 2009 Aug;15(8):946-50. doi: 10.1038/nm.1999. Epub 2009 Aug 2.

PMID:
19648929
39.

Midkine gene transfer protects against focal brain ischemia and augments neurogenesis.

Ishikawa E, Ooboshi H, Kumai Y, Takada J, Nakamura K, Ago T, Sugimori H, Kamouchi M, Kitazono T, Ibayashi S, Iida M.

J Neurol Sci. 2009 Oct 15;285(1-2):78-84. doi: 10.1016/j.jns.2009.05.026. Epub 2009 Jun 16.

PMID:
19535098
40.

Amiloride inhibits hydrogen peroxide-induced Ca2+ responses in human CNS pericytes.

Nakamura K, Kamouchi M, Kitazono T, Kuroda J, Shono Y, Hagiwara N, Ago T, Ooboshi H, Ibayashi S, Iida M.

Microvasc Res. 2009 May;77(3):327-34. doi: 10.1016/j.mvr.2008.12.001. Epub 2008 Dec 25.

PMID:
19154746
41.

Cerebral venous thrombosis associated with iron deficiency anemia.

Ogata T, Kamouchi M, Kitazono T, Kuroda J, Ooboshi H, Shono T, Morioka T, Ibayashi S, Sasaki T, Iida M.

J Stroke Cerebrovasc Dis. 2008 Nov-Dec;17(6):426-8. doi: 10.1016/j.jstrokecerebrovasdis.2008.04.008.

PMID:
18984440
42.

Polymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: the Fukuoka Stroke Registry and the Hisayama study.

Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M; Fukuoka Stroke Registry; Hisayama study.

Eur J Neurol. 2008 May;15(5):481-6. doi: 10.1111/j.1468-1331.2008.02105.x.

PMID:
18394047
43.

Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population. The Fukuoka Stroke Registry and the Hisayama Study.

Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M.

Cerebrovasc Dis. 2008;25(5):417-22. doi: 10.1159/000121342. Epub 2008 Mar 17.

PMID:
18349535
44.

Role of NHE1 in calcium signaling and cell proliferation in human CNS pericytes.

Nakamura K, Kamouchi M, Kitazono T, Kuroda J, Matsuo R, Hagiwara N, Ishikawa E, Ooboshi H, Ibayashi S, Iida M.

Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1700-7. doi: 10.1152/ajpheart.01203.2007. Epub 2008 Feb 8.

45.

Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure.

Kumai Y, Ooboshi H, Ago T, Ishikawa E, Takada J, Kamouchi M, Kitazono T, Ibayashi S, Iida M.

Exp Neurol. 2008 Apr;210(2):441-8. doi: 10.1016/j.expneurol.2007.11.028. Epub 2007 Dec 7.

PMID:
18177860
46.

Renal and carotid vascular resistance assessed with Doppler sonography.

Ohta Y, Fujii K, Ibayashi S, Matsumura K, Tsuchihashi T, Kitazono T, Ooboshi H, Kamouchi M, Hirakata H, Ogata T, Kuroda J, Iida M.

J Clin Ultrasound. 2008 Feb;36(2):85-90.

PMID:
18058931
47.

Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger.

Ifuku M, Färber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, Merrino VF, Kita S, Iwamoto T, Komuro I, Wang B, Cheung G, Ishikawa E, Ooboshi H, Bader M, Wada K, Kettenmann H, Noda M.

J Neurosci. 2007 Nov 28;27(48):13065-73.

48.

Blood pressure control in hypertensive patients with a history of stroke.

Ohta Y, Tsuchihashi T, Ibayashi S, Matsumura K, Kitazono T, Ooboshi H, Kamouchi M, Fujii K, Iida M.

J Stroke Cerebrovasc Dis. 2005 Nov-Dec;14(6):229-33.

PMID:
17904031
49.

NAD(P)H oxidase p22phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study.

Kuroda J, Kitazono T, Ago T, Ninomiya T, Ooboshi H, Kamouchi M, Kumai Y, Hagiwara N, Yoshimura S, Tamaki K, Kusuda K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Asano K, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M.

Eur J Neurol. 2007 Oct;14(10):1091-7.

PMID:
17880563
50.

[Gene therapy for cerebrovascular disease].

Ooboshi H.

Nihon Rinsho. 2006 Oct 28;64 Suppl 7:637-42. Review. Japanese. No abstract available.

PMID:
17465068

Supplemental Content

Loading ...
Support Center